avapro and triptolide
avapro has been researched along with triptolide in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Li, YS; Liu, LQ; Ma, RX; Xu, Y; Zhang, J | 1 |
| Gao, J; Liang, Z; Liu, X; Ma, N; Zhao, F | 1 |
Other Studies
2 other study(ies) available for avapro and triptolide
| Article | Year |
|---|---|
[Triptolide combined with irbesartan synergistically blocks podocyte injury in a type 2 diabetes rat model].
Topics: Animals; Biphenyl Compounds; Bone Morphogenetic Protein 7; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diterpenes; Epoxy Compounds; Irbesartan; Male; Phenanthrenes; Podocytes; Rats; Rats, Wistar; Tetrazoles; Transforming Growth Factor beta1 | 2012 |
Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy.
Topics: Animals; Apoptosis; Brain-Derived Neurotrophic Factor; Diabetes Mellitus; Diabetic Nephropathies; Diterpenes; Epoxy Compounds; Glucose; Inflammation; Irbesartan; Mice; MicroRNAs; Oxidative Stress; Phenanthrenes; Podocytes | 2022 |